Bionano Genomics, Inc. (BNGO) stock
BNGONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 12/3083% below fair value
$0.95+0.01 (+1.29%)
Close on Nov 17, 2026Market cap $11.21MP/E –Yield –
Bionano Genomics EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for Bionano Genomics
Bionano Genomics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?